From Genomics to Care

After taking weeks, human genome analysis can now be completed and its genetic variants analyzed in less than four hours, as demonstrated by a research study published in 2025 in the New England Journal of Medicine. Although these results were achieved under advanced research conditions, they reflect the magnitude of transformation underway in modern medicine and open avenues for faster diagnosis and more precise treatment decisions, particularly for children suffering from rare genetic diseases, where time can be a critical factor in their care.

In the context of these rapid developments, Kuwait recently hosted the First Conference on “Precision Pediatrics: From Genomes to Care,” organized by the Kuwait Pediatric Association and the Kuwait Academy for Rare Diseases, in collaboration with Children’s Hospital in Philadelphia, and with support from the Kuwait Foundation for the Advancement of Sciences. We were honored to participate in a lecture discussing the potential of cloud computing and its role, alongside artificial intelligence, in supporting this transformation, presenting experiences from the region and around the world.

Reading the genome does not provide us with a ready-made answer; rather, it generates vast amounts of data that require storage, processing, comparison, and interpretation. Here, the pivotal role of digital technologies emerges: cloud computing enables the rapid and efficient processing of massive genomic data, while simultaneously facilitating collaboration among healthcare providers and researchers. Artificial intelligence also aids in analyzing genetic variants and identifying patterns and relationships that may be difficult to detect using traditional methods. However, these capabilities do not replace human expertise, which remains fundamental to interpreting results, verifying them, and making medical decisions. Speed alone does not create precision medicine unless it is coupled with accuracy, trust, and responsibility, thereby contributing to improved patient care and quality of life.

Kuwait possesses a scientific and health heritage worthy of pride and further development, ranging from the establishment of the University of Kuwait and its Faculty of Medicine, to the resilience of our healthcare workforce during the brutal Iraqi invasion and the coronavirus pandemic, and our early leadership in genetics with the founding of the Kuwait Center for Genetic Diseases in 1979. Today, we have an opportunity to continue this journey through the state’s digital investments and cloud partnerships, leveraging computing and artificial intelligence to advance scientific research and precision medicine services, enhancing our capacity to transition from genetic knowledge to more accurate and effective healthcare.

However, seizing this opportunity requires more than merely acquiring technologies or collecting more data; it demands an integrated national vision, sustainable investment in scientific research and national talent, development of digital infrastructure, and strengthened collaboration among health, academic, research institutions, and the private sector. Equally important is establishing governance for genomic information, which defines responsibilities and authorities, regulates its collection, storage, sharing, and use, protects individual privacy and rights, and enables its responsible utilization in research, diagnosis, and treatment.

Success is not measured by the number of genomes we read, but by the diagnostic journey we shorten, the treatment decisions we improve, and the value we add to patients’ quality of life. Undoubtedly, the greatest achievements are not realized in isolation, but through the integration of sciences, expertise, and institutions, and by harnessing technology to serve humanity, safeguard health, and enhance quality of life. Only then does scientific knowledge translate into tangible impact, and we move from the genome to care.

Dr. Dhafer Adel Al-Huwail